Am J Transplant, Volume 21, Suppl 3 Archives - Page 6 of 139 - ATC Abstracts

2021 American Transplant Congress
Continuous 24-Hour Antithymocyte Globulin (ATG) for Renal Allograft Rejection: Results of a Randomized Controlled Trial
S. J. Patel, A. Rogers, S. Kuten, R. Knight, E. Graviss, D. Nguyen, T. Ellimuttil, I. Agboli, L. Gaber, A. Gaber
Houston Methodist Hospital, Houston, TX
*Purpose: For acute renal allograft rejection (AR), ATG is generally administered in the inpatient setting because of the need for intravenous access, patient monitoring, and…
2021 American Transplant Congress
Early Hypertransaminasemia in Kidney Transplant Recipient: Influence of Donor Type and Clinical Significance
E. Solà-Porta, M. Redondo-Pachón, S. Núñez-Delgado, C. Arias-Cabrales, M. Mir, A. Buxeda, C. Burballa, M. Crespo, J. Pascual, M. Pérez-Sáez
Nephrology, Hospital del Mar, Barcelona, Spain
*Purpose: The increase in transaminases after kidney transplant (KT) is frequent. Although the cause is unknown, it has been associated with factors such as immunosuppression,…
2021 American Transplant Congress
Rabbit Anti-thymocyte Globulin Induction Dosing Strategies in a High-risk Kidney Transplant Population
C. Nguyen, R. Yau, C. Tunwar
Pharmacy, CHI Baylor St. Luke's Medical Center, Houston, TX
*Purpose: The objective of this retrospective observational study is to compare the safety and efficacy of two dosing strategies, rabbit anti-thymocyte globulin (rATG) at a…
2021 American Transplant Congress
Association of Belatacept Conversion on Patient and Allograft Survival in Kidney Transplant Recipients with Congestive Heart Failure
H. Mogallapalli
Department of Medicine, University of Wisconsin-Madison, Madison, WI
*Purpose: Calcineurin inhibitors (CNI) exert deleterious effect on cardiovascular risk in kidney transplant recipients (KTRs). Belatacept conversion may reduce CV risk in KTRs. We hypothesized…
2021 American Transplant Congress
Awareness of Teratogenic Potential of Mycophenolic Acid Products and Pregnancy Outcomes in Kidney Transplant Recipients
S. Rao¹, L. Coscia², A. Yusuf², S. Constantinescu³, M. J. Moritz⁴
¹Nephrology, University of Virginia Heath System, Charlottesville, VA, ²Transplant Pregnancy Registry International, Philadelphia, PA, ³Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, ⁴Surgery, Lehigh Valley Health Network, Allentown, PA
*Purpose: In 2006, Transplant Pregnancy Registry International (TPRI) reported teratogenic effects of mycophenolic acid products (MPA) in pregnancies in transplant recipients. This resulted in black…
2021 American Transplant Congress
Which Living Kidney Donors Arrive to the Donation Process Informed About Surgery?
L. Malinzak, A. Segal, R. Prashar, M. Jesse
Henry Ford Hospital, Detroit, MI
*Purpose: To evaluate perceived knowledge about surgery in potential living kidney donors embarking on the donation process.*Methods: Potential living kidney donors were surveyed about their…
2021 American Transplant Congress
Robotic versus Open Mini-incision Living Donor Nephrectomy: Single Center Experience
S. Lee¹, S. Z. Wang², A. Khan¹, A. Sharma¹, D. Kumar³, L. Kamal³, A. Cotterell¹, V. Kumaran¹, D. Bruno¹, M. Levy¹, C. Bhati¹
¹Transplant Surgery, Virginia Commonwealth University hospital, Richmond, VA, ²Medical School, Virginia Commonwealth University, Richmond, VA, ³Transplant Nephrology, Virginia Commonwealth University hospital, Richmond, VA
*Purpose: A minimally invasive approach is the gold standard for living donor nephrectomy (LDN). While robotic surgery is commonly used for native nephrectomies and urological…
2021 American Transplant Congress
The Use of Donor Derived Cell Free DNA in Children to Monitor Therapy of Kidney Rejection
A. Al-Uzri, M. Wright, K. Clark, R. Jenkins
Oregon Health & Science Univ, Portland, OR
*Purpose: Elevated donor-derived cell-free DNA (dd-cfDNA) in the presence of HLA donor-specific antibodies (DSA) are shown to correlate with acute antibody-mediated rejection (AMR) in adult…
2021 American Transplant Congress
To Whom do Pediatric Donor Organs Go?
J. Smith¹, M. Skeans², R. Engen³, S. Bartosh⁴
¹Seattle Children's Hospital, Seattle, WA, ²SRTR, Minneapolis, MN, ³Lurie Children's Hospital, Chicago, IL, ⁴Univ of Wisconsin, Madison, WI
*Purpose: Pediatric priority in organ allocation is mandated by the Final Rule, but prioritization varies by organ, sometimes informed by size-matching needs. Heart (Policy 6.6.E)…
2021 American Transplant Congress
Combined Impact of Pre-sensitization and Delayed Graft Function on Allograft Rejection in Deceased Donor Kidney Transplantation: A Nationwide Cohort Study
H. Lee¹, Y. Park¹, T. Ban², S. Song³, S. Song⁴, J. Yang⁵, C. Ahn⁵, C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s hospital, Seoul, Korea, Republic of, ²Division of Nephrology, Department of Internal Medicine, Eunpyeong St. Mary’s hospital, Seoul, Korea, Republic of, ³Organ Transplantation Center and Department of Internal Medicine, Pusan National University Hospital, Pusan, Korea, Republic of, ⁴Department of Surgery, Ewha Womans University Medical Center, Seoul, Korea, Republic of, ⁵Department of Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study is to investigate whether or not delayed graft function (DGF) and pre-transplant sensitization has a synergistic adverse effect on…

« Previous Page
1
…
4
5
6
7
8
…
139
Next Page »